Saito, Y., Hayashi, R., Iida, Y., Mizumachi, T., Fujii, T., Matsumoto, F., Beppu, T., Yoshida, M., Shinomiya, H., Kamiyama, R., Kitano, M., Yokoshima, K., Fujimoto, Y., Hama, T., Yamashita, T., Okami, K., Miura, K., Fujisawa, T., Sano, D., Kato, H., Minami, S., Sugasawa, M., Masuda, M., Ota, I., Iwae, S., Kawata, R., Monden, N., Imai, T., Asakage, T., Okada, M., Yoshikawa, T., Tanioka, K., Kitayama, M., Doi, M., Fujii, S., Fujii, M., Oridate, N., Nakamizo, M., Yoshimoto, S., Homma, A., Nibu, K., & Yane, K. (2020). optimization of therapeutic strategy for p16‐positive oropharyngeal squamous cell carcinoma: Multi‐institutional observational study based on the national Head and Neck Cancer Registry of Japan. Cancer, 126(18), 4177–4187. http://access.bl.uk/ark:/81055/vdc_100106916744.0x00005f